S. Bloch

发表

Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010.

Michael Larsen, M. Larsen, I. C. Munch, 2012, American journal of ophthalmology.

Fibrosis of extramacular angioid streaks following ranibizumab treatment of subfoveal choroidal neovascularization

M. Larsen, S. Bloch, 2011, Acta ophthalmologica.

Translational public health care perspective: Intravitreal treatment of neovascular age‐related macular degeneration has revolutionized clinical ophthalmology

M. Larsen, S. Bloch, 2015, Acta ophthalmologica.

Predictors of 1‐year visual outcome in neovascular age‐related macular degeneration following intravitreal ranibizumab treatment

M. Larsen, H. Lund‐Andersen, B. Sander, 2013, Acta ophthalmologica.

Contraction of occult choroidal neovascular membrane and rupture of the retinal pigment following verteporfin and bevacizumab treatment

M. Larsen, S. Bloch, A. A. Abdel Hadi, 2011, Acta ophthalmologica.

Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab.

M. Larsen, H. Lund‐Andersen, B. Sander, 2013, American journal of ophthalmology.

Patient compliance in glaucoma.

A. Rosenthal, S. Bloch, L. Friedman, 1977, The British journal of ophthalmology.

Implementation studies of ranibizumab for neovascular age‐related macular degeneration

S. Bloch, 2013, Acta ophthalmologica.

A 4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degeneration.

M. Larsen, H. Lund‐Andersen, B. Sander, 2013, Ophthalmology.